EUVIMEDScopri EUVIMED
Randomisierte kontrollierte Studie

The effect of atomoxetine and methylphenidate on emotional dysregulation in children with attention deficit/hyperactivity disorder: a multicenter randomized clinical trial

Yuan Gao, Zhaomin Wu iD, Binrang Yang, Wai Chen iD, Chen Dang, Yu Zhu, Meirong Pan, Min Dong, Haimei Li, Mengjie Zhao, Xinxin Yue, Haifei Guo and 6 more

Journal of Child Psychology and Psychiatry · 2026-08-10

DOI: 10.1111/jcpp.70217 ↗

At a glance

Randomisierte kontrollierte Studie in Journal of Child Psychology and Psychiatry, published online on 2026-08-10. Written by Yuan Gao and 17 co-authors. Institution: Peking University Sixth Hospital/Institute of Mental Health, National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital…. Cited 1 times so far (Crossref); 71 references. Funded by: Beijing Nova Program, Capital's Funds for Health Improvement and Research, Clinical Medicine Plus X - Young Scholars Project, Peking University.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Background

This study aimed to compare the effects of atomoxetine (ATX) and methylphenidate (MPH) on emotional dysregulation (ED) in children with attention deficit/hyperactivity disorder (ADHD), and to explore potential neural correlates underlying treatment‐related changes.

Methods

A total of 152 children with ADHD were randomly assigned to receive ATX ( n = 76) or MPH ( n = 76). After individualized dose titration, participants received a stable dose for 4 weeks. Emotional lability (EL) was the primary outcome, while emotion regulation strategies, ADHD symptoms, and overall illness severity were secondary outcomes. Mixed‐effects linear models were applied to examine group differences across three time points (baseline, post‐titration, and endpoint). Resting‐state functional MRI data were acquired at baseline and endpoint and analyzed using whole‐brain functional connectivity (FC) analysis with six amygdala subregions as seeds.

Trial registration

ChiCTR2200062905; approved on August 23, 2022.

Results

In both ATX and MPH groups, EL scores decreased significantly over time (β = −1.54, p < .001), with treatment effects in a similar range and no statistically significant between‐group difference (MPH: d = −1.46; ATX: d = −0.93). After controlling for ADHD symptom improvement, treatment effects remained significant (β = −0.75, p < .001), suggesting that EL improvement was not solely accounted for by ADHD symptom reduction. Increased FC between the right basolateral amygdala and left orbital middle frontal gyrus ( r = −0.46, p = .043), and between the left superficial amygdala and left middle cingulate cortex ( r = −0.48, p = .031), was associated with EL changes and remained significant after controlling for ADHD symptom changes. No significant changes were found in self‐reported emotion regulation strategies.

Conclusions

ATX and MPH both alleviate ED in children with ADHD, and these effects are not solely accounted for by improvements in ADHD symptoms. Increased amygdala‐centered FC may be associated with medication‐related ED improvements.

Subjects

Author keywords

ADHDatomoxetinebrain imagingemotional dysregulationmethylphenidate

Authors and institutions

  • Peking University Sixth Hospital/Institute of Mental Health, National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, China.
  • NHC Key Laboratory of Mental Health (Peking University), Beijing, China.
  • Shenzhen Children's Hospital, Shenzhen, China.
  • Curtin Medical School, Curtin University, Perth, WA, Australia.
  • Postgraduate Centre of Training in Psychiatry, North Metropolitan Health Service, Perth, WA, Australia.
  • Service 5, South Metropolitan Health Service, Perth, WA, Australia.

ORCID profiles: Zhaomin Wu, Wai Chen, Li Sun, Lu Liu

Funding

  • Beijing Nova Program
  • Capital's Funds for Health Improvement and Research
  • Clinical Medicine Plus X - Young Scholars Project, Peking University
  • National Natural Science Foundation of China
  • Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences

Cite

APA

Gao, Y., Wu, Z., Yang, B., Chen, W., Dang, C., Zhu, Y., Pan, M., Dong, M., Li, H., Zhao, M., Yue, X., Guo, H., Fu, S., Su, Y., Wang, Y., Qian, Q., Sun, L., & Liu, L. (2026). The effect of atomoxetine and methylphenidate on emotional dysregulation in children with attention deficit/hyperactivity disorder: a multicenter randomized clinical trial. Journal of Child Psychology and Psychiatry. https://doi.org/10.1111/jcpp.70217

Vancouver

Gao Y, Wu Z, Yang B, Chen W, Dang C, Zhu Y, et al. The effect of atomoxetine and methylphenidate on emotional dysregulation in children with attention deficit/hyperactivity disorder: a multicenter randomized clinical trial. Journal of Child Psychology and Psychiatry. 2026. doi:10.1111/jcpp.70217

BibTeX
@article{Gao2026,
  author = {Gao, Yuan and Wu, Zhaomin and Yang, Binrang and Chen, Wai and Dang, Chen and Zhu, Yu and Pan, Meirong and Dong, Min and Li, Haimei and Zhao, Mengjie and Yue, Xinxin and Guo, Haifei and Fu, Shan and Su, Yi and Wang, Yufeng and Qian, Qiujin and Sun, Li and Liu, Lu},
  title = {The effect of atomoxetine and methylphenidate on emotional dysregulation in children with attention deficit/hyperactivity disorder: a multicenter randomized clinical trial},
  journal = {Journal of Child Psychology and Psychiatry},
  year = {2026},
  doi = {10.1111/jcpp.70217}
}
Start for free →